CSI Market
Sign In | Register

Astrazeneca Plc (AZN) Annual Income Statement

Annual · GAAP · USD millions
Access AZN quarterly income statements →
This page allows investors to track Astrazeneca Plc's income statement performance across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
2025 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Revenues
Sales of Products0.00
Total Revenue58,739.00
Costs & Expenses
Cost of Goods and Services Sold10,633.00
Gross Profit48,106.00
Selling, Administration, Marketing19,933.00
Depreciation & Amortization0.00
Research and Development Expense14,232.00
OtherOperating Income Expense381.00
Total operating costs including COS44,996.00
Operating income / -loss13,743.00
Net Interest (-)Expense / Income0.00
Other loss / -income7.00
Total costs & expenses46,337.00
Income & Taxes
Income / -loss before income taxes12,402.00
Income taxes expenses / -benefit2,169.00
Income after income taxes10,233.00
Income / -loss from continuing operations10,233.00
Non-controlling interests16.00
Net income / -loss10,233.00
Income / -loss to shareholder10,225.00
EBIT12,402.00
EBITD18,135.00
EBITDA18,135.00
Earnings Per Share
Basic EPS (excl. extra items)6.60
Basic Net EPS6.60
Basic shares outstanding (Mill. of Units)1,550.00
Diluted Net EPS6.55
Diluted average shares (Mill. of Units)1,562.00
Dividend per share6.36
4 historic quarters locked

Sign in to unlock the full Astrazeneca Plc income statement history.

Sign In Create Free Account

About AZN Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.